CXCR4 mRNA overexpression: an indicator of poor survival and predictor of response to immune checkpoint inhibitors in patients with metastatic colorectal cancer.
- DOI
- 10.1136/bmjonc-2025-001003
- Published
- 2026
- Container
- BMJ oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/bmjonc-2025-001003,
title = {CXCR4 mRNA overexpression: an indicator of poor survival and predictor of response to immune checkpoint inhibitors in patients with metastatic colorectal cancer.},
author = {Gholami S and Saeed A and Baca Y and Hinton A and Demyan L and Abidalhassan M and Xiu J and Manji GA and Seeber A and Weinberg BA and Khushman M and Shields AF and Lenz HJ and Marshall J and Lou E},
year = {2026},
journal = {BMJ oncology},
doi = {10.1136/bmjonc-2025-001003},
url = {https://doi.org/10.1136/bmjonc-2025-001003}
}RIS
TY - JOUR TI - CXCR4 mRNA overexpression: an indicator of poor survival and predictor of response to immune checkpoint inhibitors in patients with metastatic colorectal cancer. AU - Gholami S AU - Saeed A AU - Baca Y AU - Hinton A AU - Demyan L AU - Abidalhassan M AU - Xiu J AU - Manji GA AU - Seeber A AU - Weinberg BA AU - Khushman M AU - Shields AF AU - Lenz HJ AU - Marshall J AU - Lou E PY - 2026 JO - BMJ oncology DO - 10.1136/bmjonc-2025-001003 UR - https://doi.org/10.1136/bmjonc-2025-001003 ER -
APA
S, G., A, S., Y, B., A, H., L, D., M, A., J, X., GA, M., A, S., BA, W., M, K., AF, S., HJ, L., J, M., & E, L. (2026). CXCR4 mRNA overexpression: an indicator of poor survival and predictor of response to immune checkpoint inhibitors in patients with metastatic colorectal cancer.. BMJ oncology. https://doi.org/10.1136/bmjonc-2025-001003
Source records
- pubmed · retrieved 2026-09-26T08:34:32.729Z